ATE326954T1 - Transdermales therapeutisches system zur verabreichung von calciumantagonisten - Google Patents

Transdermales therapeutisches system zur verabreichung von calciumantagonisten

Info

Publication number
ATE326954T1
ATE326954T1 AT00945862T AT00945862T ATE326954T1 AT E326954 T1 ATE326954 T1 AT E326954T1 AT 00945862 T AT00945862 T AT 00945862T AT 00945862 T AT00945862 T AT 00945862T AT E326954 T1 ATE326954 T1 AT E326954T1
Authority
AT
Austria
Prior art keywords
administration
transdermal therapeutic
calcium antagonists
therapeutic system
antagonists
Prior art date
Application number
AT00945862T
Other languages
English (en)
Inventor
Achim Berthold
Walter Mueller
Giovanni Gaviraghi
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of ATE326954T1 publication Critical patent/ATE326954T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00945862T 1999-07-22 2000-07-04 Transdermales therapeutisches system zur verabreichung von calciumantagonisten ATE326954T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9917290.0A GB9917290D0 (en) 1999-07-22 1999-07-22 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE326954T1 true ATE326954T1 (de) 2006-06-15

Family

ID=10857791

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00945862T ATE326954T1 (de) 1999-07-22 2000-07-04 Transdermales therapeutisches system zur verabreichung von calciumantagonisten

Country Status (8)

Country Link
EP (1) EP1196151B1 (de)
JP (1) JP2003505411A (de)
AT (1) ATE326954T1 (de)
AU (1) AU5981200A (de)
DE (1) DE60028207T2 (de)
ES (1) ES2265350T3 (de)
GB (1) GB9917290D0 (de)
WO (1) WO2001007017A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100413490C (zh) * 2003-05-14 2008-08-27 沈阳药科大学 难溶性药物透皮吸收制剂及其制备工艺
CA2651596C (en) * 2006-05-08 2014-03-25 Teikoku Seiyaku Co., Ltd. Percutaneous absorption preparations of antidementia drugs
WO2014028049A1 (en) * 2012-08-15 2014-02-20 Dow Corning Corporation Multi - layer transdermal drug delivery system
DE102020107937A1 (de) * 2020-03-23 2021-09-23 Lts Lohmann Therapie-Systeme Ag DMEH - Enhancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
JPH02149514A (ja) * 1988-04-06 1990-06-08 Nitto Denko Corp 医薬部材
ES2062093T3 (es) * 1988-08-02 1994-12-16 Ciba Geigy Ag Emplasto de varias capas.
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
US6106856A (en) * 1994-03-09 2000-08-22 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Transdermal delivery of calcium channel blockers, such as nifedipine
EP1150675B1 (de) * 1999-02-09 2006-02-01 Samyang Corporation Transdermale zusammenstellung eines antibrechmittelsund eine zubereitung die dasselbe enthält

Also Published As

Publication number Publication date
WO2001007017A1 (en) 2001-02-01
ES2265350T3 (es) 2007-02-16
DE60028207D1 (de) 2006-06-29
AU5981200A (en) 2001-02-13
JP2003505411A (ja) 2003-02-12
EP1196151B1 (de) 2006-05-24
DE60028207T2 (de) 2007-03-08
EP1196151A1 (de) 2002-04-17
GB9917290D0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
NO20002785L (no) Adamantanderivater
NO20002786L (no) Adamantanderivater
DE3879853T2 (de) Klebstoffzusammensetzung, Zusammensetzung mit kontrollierter Wirkstofffreisetzung und System zur transdermalen Anwendung von Arzneien.
DE69203990T2 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE69725860D1 (de) PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN
HK1068606A1 (en) Novel aminobenzoephenones
DE69711078T2 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
ATE241338T1 (de) Arzneistoffabgabesystem, insbesondere zur verabreichung von androgenen
DE50108168D1 (de) Transdermales therapeutisches system zur abgabe von lerisetron
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
DE50011653D1 (de) Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure
ATE295157T1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
ATE326954T1 (de) Transdermales therapeutisches system zur verabreichung von calciumantagonisten
NO20000814L (no) Identifikasjon for klebende flateformede dermale og transdermale terapeutiske administrasjonsformer under anvendelse av et klebende plaster som informasjonsbærer, såvel som fremgangsmåte for deres fremstilling
BR0112131A (pt) Composições farmacêuticas e métodos para uso
SE9902597D0 (sv) New use
ATE228843T1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
HUP9801075A2 (hu) Kombinált állandó dózisú angiotenzint átalakító enzim inhibítor kalciumcsatorna-antagonista, eljárás ennek előállítására, valamint alkalmazása szív- és érrendszeri betegségek kezelésében
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
PT1231908E (pt) Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties